Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002734

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 29, 2014
Accepted (ET)
Mar 29, 2018 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 24, 2014P6,200$2.23A1,856,877ISee Footnote
Common StockF3Dec 24, 2014P6,200$2.23A1,330,994D
Common StockF1,F2Dec 29, 2014P600$2.47A1,857,477ISee Footnote
Common StockF3Dec 29, 2014P600$2.47A1,331,594D
Common StockF1,F2Dec 30, 2014P6,400$2.43A1,863,877ISee Footnote
Common StockF3Dec 30, 2014P6,400$2.43A1,337,994D
Common StockF1,F2Dec 30, 2014P10,000$2.41A1,873,877ISee Footnote
Common StockF3Dec 30, 2014P10,000$2.41A1,347,994D
Common StockF1,F2Dec 31, 2014P22,600$2.62A1,896,477ISee Footnote
Common StockF3Dec 31, 2014P22,600$2.62A1,370,594D
Common StockF1,F2Dec 31, 2014P8,500$2.58A1,904,977ISee Footnote
Common StockF3Dec 31, 2014P8,500$2.58A1,379,094D
Common StockF1,F2Feb 26, 2015P100$2.52A1,905,077ISee Footnote
Common StockF3Feb 26, 2015P100$2.52A1,379,194D
Common StockF1,F2Mar 3, 2015P500$2.62A1,905,577ISee Footnote
Common StockF3Mar 3, 2015P500$2.62A1,379,694D
Common StockF1,F2Mar 9, 2015P1,000$2.54A1,906,577ISee Footnote
Common StockF3Mar 9, 2015P1,000$2.54A1,380,694D
Common StockF1,F2Mar 13, 2015P18,000$2.59A1,924,577ISee Footnote
Common StockF3Mar 13, 2015P18,000$2.59A1,398,694D
Common StockF1,F2Mar 24, 2015P5,000$2.50A1,929,577ISee Footnote
Common StockF3Mar 24, 2015P5,000$2.50A1,403,694D
Common StockF1,F2Mar 25, 2015P2,000$2.61A1,931,577ISee Footnote
Common StockF3Mar 25, 2015P2,000$2.61A1,405,694D
Common StockF1,F2Mar 31, 2015P5,000$2.44A—ISee Footnote
Common StockF3Mar 31, 2015P5,000$2.44A1,410,694D
Common StockF1,F2Apr 10, 2015P3,000$2.33A1,939,577ISee Footnote
Common StockF3Apr 10, 2015P3,000$2.33A1,413,694D
Common StockF1,F2Apr 23, 2015P6,000$2.35A1,945,577ISee Footnote
Common StockF3Apr 23, 2015P6,000$2.35A1,419,694D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

(+) This is the second part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.